S&P 500
7,226.20
+0.01%
Dow Jones
49,494.60
-0.62%
Nasdaq 100
27,685.40
+0.66%
Russell 2000
2,804.78
-0.02%
FTSE 100
10,364.50
0.00%
Nikkei 225
59,260.50
-0.78%

Investing

SLNO logo Soleno Therapeutics : SLNO

SLNO

Stock Data

$52.87

Change up

$0.05 (0.09%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Soleno Therapeutics, Inc. is a biopharmaceutical company dedicated to developing treatments for rare diseases. Its flagship project involves Diazoxide Choline Extended-Release tablets, aimed at treating Prader-Willi Syndrome, currently in Phase III trials. Originating in 1999 and initially known as Capnia, Inc., the company rebranded to its current name in 2017 and operates from Redwood City, California.

All Soleno Therapeutics Articles

1 Article